Indivior Pharmaceuticals, Inc. (INDV)
NASDAQ: INDV · Real-Time Price · USD
34.37
-0.40 (-1.15%)
Sep 10, 2026, 3:34 PM EDT - Market open
Indivior Pharmaceuticals Market Cap
Indivior Pharmaceuticals has a market cap or net worth of $4.06 billion as of September 10, 2026. Its market cap has increased by 31.83% in one year.
Market Cap
4.06B
Enterprise Value
4.34B
1-Year Change
31.83%
Ranking
Category
Stock Price
$34.37
ChartMarket Cap Chart
Since December 29, 2014, Indivior Pharmaceuticals's market cap has increased from $1.53B to $4.06B, an increase of 165.01%. That is a compound annual growth rate of 8.68%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 10, 2026 | 4.06B | -9.46% |
| Dec 31, 2025 | 4.48B | 188.39% |
| Dec 31, 2024 | 1.55B | -25.50% |
| Dec 29, 2023 | 2.09B | -29.77% |
| Dec 29, 2022 | 2.97B | 22.55% |
| Dec 31, 2021 | 2.42B | 125.44% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Lantheus Holdings | 6.56B |
| Hims & Hers Health | 6.44B |
| Liquidia | 6.09B |
| Kiniksa Pharmaceuticals International, | 5.94B |
| Amneal Pharmaceuticals | 5.89B |
| Amylyx Pharmaceuticals | 4.03B |
| Regencell Bioscience Holdings | 2.84B |
| Supernus Pharmaceuticals | 2.40B |